High prevalence of chromosome 17 in breast cancer micronuclei: a means to get rid of tumor suppressors?
Authors:
- 22 October 2024
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 38 (1) , 1-12
Abstract
Micronuclei (MN), defined as small extra-nuclear chromatin bodies enclosed by a nuclear envelope, serve as noticeable markers of chromosomal instability (CIN). The MN have been used for breast cancer (BC) screening, diagnosis, and prognosis. However, more recently they have gained attention as seats for active chromosomal rearrangements. BC subtypes exhibit differential CIN levels and aggressiveness. This study aimed to investigate MN chromosomal contents across BC subtypes, exploring its potential role in aggressiveness and pathogenesis. Immunostaining of BC cells was performed with anti-centromeric antibody followed by confocal microscopy. Further, fluorescence in situ hybridization (FISH) was done to check the presence of specific chromosomes in the MN. The real time PCR was also done from the RNA isolated from MN to check the expression of TP53 gene. BC cell lines (CLs) showed the presence of both centromere-positive ( +) and -negative ( −) MN, with significant variation in frequency among hormone and human epidermal growth factor receptor positive and triple-negative (TN) BC cells. FISH targeting chromosomes 1, 3, 8, 11, and 17 detected centromeric signals for all the above chromosomes in MN with a relatively higher prevalence of chromosome 17 in all the CLs. Out of all the CLs, TNBC cells demonstrated the highest frequency of centromere + and chromosome 17 + MN. TP53 expression could also be demonstrated inside the MN by FISH and real time PCR. Patient sample imprints also confirmed the presence of chromosome 17 in MN with polysomy of the same in corresponding nuclei. The high prevalence of chromosome 17 in BC MN may connote the importance of its rearrangements in the pathogenesis of BC. Further, the higher prevalence of chromosome 17 and 1 signals in TNBC MN point towards the significance of pathogenetic events involving the genes located in these chromosomes in evolution of this more aggressive phenotype.Keywords
This publication has 44 references indexed in Scilit:
- Current and future burden of breast cancer: Global statistics for 2020 and 2040The Breast, 2022
- Causes and consequences of micronucleiCurrent Opinion in Cell Biology, 2021
- Small but strong: Mutational and functional landscapes of micronuclei in cancer genomesInternational Journal of Cancer, 2020
- Understanding the birth of rupture-prone and irreparable micronucleiChromosoma, 2020
- Validation of the γH2AX biomarker for genotoxicity assessment: a reviewArchives of Toxicology, 2019
- Micronucleus formation in human cancer cells is biased by chromosome sizeGenes, Chromosomes and Cancer, 2018
- Aneuploidy: Cancer strength or vulnerability?International Journal of Cancer, 2018
- Genomic and Functional Approaches to Understanding Cancer AneuploidyCancer Cell, 2018
- Chromosomal changes: induction, detection methods and applicability in human biomonitoringBiochimie, 2006
- p53 accumulates in micronuclei after treatment with a DNA breaking chemical, methylnitrosourea, and with the spindle poison, vinblastineMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996